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Abstract 
A placebo treatment is traditionally administered in a double-blind, randomized controlled 
trial to control for the ‘real’ effects of the treatment under investigation. In the present paper a 
broader view of the placebo is proposed, one in which the idea of a potentially ‘useable’ 
placebo component of a sports or exercise medicine treatment is presented. It is argued that 
many interventions in sport and exercise psychology might contain a placebo component that 
could be capitalized upon by practitioners, through processes often as simple as 
communicating positive expectations of a treatment to clients. Research findings relating to 
factors that might influence an individual’s response to a placebo, such as personality, 
situation and genetics, are briefly addressed. Ethical considerations for practice and future 
research are discussed.  
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Introduction 
The placebo effect is a positive outcome arising from the belief that a beneficial treatment has 
been received  (11). It has been termed the ‘belief effect’ (12) and the ‘meaning effect’ (24). 
A negative belief effect, the ‘nocebo effect’ (16) is a negative outcome resulting from the 
belief that a desired treatment has not been received, or that a received treatment is harmful.  
The inclusion of the placebo control in the double-blind randomized controlled trial is 
regarded as the ‘gold standard’ for biomedical research. Researchers gain confidence about 
any ‘real’ effects of a treatment when it is compared to a placebo control condition which is, 
theoretically at least, indistinguishable from the treatment under examination. Participants in 
a trial are therefore, in theory, unaware as to whether they are receiving the placebo or the 
real treatment. This allows researchers to identify whether observed effects are the direct 
result of the biological, pharmacological or mechanical qualities of the treatment, cognitive 
factors such as expectation, cognitive-behavioral factors such as conditioning, or 
psychophysiological (emotional) responses such as reduced anxiety. 
As well as employing placebo controls in research examining, for example, the effects of 
ergogenic aids on sports performance, sports scientists have also investigated the direct 
effects on performance of placebos purporting to be ergogenic aids (5, 7, 8, 13, 29). 
Collectively these studies demonstrate that when athletes believe that they have received a 
beneficial treatment, even when this treatment is a placebo, the performance of a significant 
percentage of those athletes is enhanced. Work in sport has also addressed potential 
mechanisms and implications (3, 4, 6, 34). This body of research has arguably presented 
interesting data relating to the direction, magnitude, and frequency of the placebo effect in 
sport, with implications both for research and practice. For example, whilst it has been 
reported that the belief that a beneficial treatment has been received might significantly 
enhance performance, it is also evident that:   
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 Athletes’ beliefs can result in both positive (placebo) and negative (nocebo) effects on 
performance 
 Placebo effects may be experienced both objectively (e.g. improved performance) 
and/or subjectively (e.g. reduced pain or exertion) 
 Not all participants are placebo responsive, or at least, not all athletes are placebo 
responsive all of the time 
However, whilst traditional treatment/control designs are used in much ergogenics and 
placebo effect research (albeit deceptively in the latter case), that design cannot answer many 
of the more interesting questions relating to the placebo effect, for example whether there are 
any interactions between a treatment and the belief that the treatment will improve 
performance (10, 25). Researchers in sport have therefore used the four condition balanced 
placebo design (BPD: Figure 1) , which allows assessment of each possible combination of 
what the athlete believes they have taken (i.e. placebo or drug) and what the athlete has 
actually taken (again, placebo or drug) (8, 13, 22, 23). Collectively, findings suggest that the 
‘real’ (i.e. biological, pharmacological or mechanical) and placebo (i.e. psychological) 
components of a treatment often interact to influence performance or other sports related 
variables such as pain or perceived exertion. These findings have implications for sports 
medicine practitioners, specifically in ensuring that athletes believe that a treatment will be 
effective.  
Applied psychology and the placebo effect 
Psychology is the science of behavior. Many of the key processes employed by practitioners 
in sports performance enhancement and in sports medicine, whilst grounded in the biological 
and mechanical sciences, are essentially psychological. That is, practitioners in sports-related 
professions such as coaching, physiotherapy, nutrition, biomechanics and physiology are 
often interested in change in one or more target behaviors; it is therefore not unreasonable to 
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argue that most expert sports practitioners are also expert applied psychologists. Whilst most 
sports professionals are of course not licensed psychologists (with the obvious exception of 
sports psychologists, which we return to below), there exists a substantial overlap between 
the day to day work of both.     
Sport psychology is of course an applied and licensed discipline in its own right. The day to 
day work of many sports psychologists will include dealing with a range of psychosocial 
variables including motivation, competitive anxiety, confidence, decision making and 
concentration. Several key variables of applied sports psychology, but specifically confidence 
and anxiety, are in essence beliefs. Self-confidence is the belief we have in our own or our 
team’s ability, or the belief that we will recover from an injury, or the belief in our ability to 
maintain a strict athletic diet. Anxiety on the other hand is the belief that we might not have 
the ability to meet an upcoming challenge, to recover from an injury, or maintain the diet. 
Furthermore, confidence and anxiety are often catalyzed by further broader beliefs about 
ourselves.  
Sport psychologists often have to modify the beliefs of their athletes to enable those athletes 
to perform to a higher level. For example, an under-confident athlete who suffers from tunnel 
vision might require a confidence-boosting strategy alongside work on correct attentional 
focus, while an over-confident athlete who is not sufficiently focused on the task in hand 
might need reminding of the seriousness of the challenge ahead and of the potential threat 
that the opponent poses. It could be argued that, by modifying organic (i.e., naturally 
occurring) levels of confidence or anxiety, a sport psychologist is actually catalyzing a false – 
or at least currently unjustified – belief, in order to bring about a positive outcome. Does this 
sound familiar? In other words, many interventions in sport and exercise psychology might 
operate in part via a placebo effect. 
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Surprising though this might sound, the issue has been the subject of research in clinical and 
counseling psychology for many years. In fact, the charge that psychotherapy might exert its 
effect via a placebo mechanism is not the worst to be aimed at it; that is, it has not only been 
suggested that many forms of psychotherapy are no better than a placebo, but that they may 
even be no better than no-treatment (31, 32). Research has also suggested that the beliefs of 
the practitioner about a treatment might be a significant factor in the success of that treatment 
(9). Therefore in any therapeutic setting, the magnitude of any placebo effect might be driven 
by the beliefs of both practitioner and patient/client. This has often been cited as the 
mechanism underlying many examples of ‘faith healing’ (24).  
The idiosyncrasies of a treatment may also impact the nature and magnitude of the response 
to treatment; the participants’ belief in a treatment can be affected by its physical 
characteristics. For example, Szabo et al. (33) revealed how perceptual properties of sports 
ergogenic supplements (e.g. shape, size, color) influence its perceived effectiveness, and 
effects can be quite specific. Athletes perceived a white powder to be more effective for 
strength, compared to endurance or concentration, whereas a green gel was perceived to be 
more effective for endurance than strength and concentration. It could be speculated that even 
before an athlete has been given information about a treatment, on the basis of perceptual 
information received, the athlete has already made up his/her mind on whether it will be 
effective or not. 
It is fair to say that, in many respects, whether an intervention operates via what we term 
‘real’ or what we term ‘placebo’ mechanisms is not important. If it works, it works. If an 
athlete runs faster because they believe that they have ingested 450mg of caffeine when they 
have not, or if the same athlete runs faster because they believe that their sport psychologist 
has resolved their anxiety issue, the athlete is still running faster. Perhaps the placebo effect 
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and many sports psychology interventions operate in the same gap between what is currently 
being achieved and what is achievable?  
Placebo responsiveness 
Placebo effects are traditionally viewed as a positive phenomenon. Indeed, the common sense 
model of the placebo effect is one in which an individual benefits from false information such 
as “the tablet I am about to give you will enhance your power output in the upcoming 
competition”. However, post-experimental interview data (7) revealed that enhanced 
performance in placebo trials was often coupled with positive changes in psychological 
factors such as confidence, motivation, and arousal. These findings suggest that the placebo 
effect may be reflective of a sub-optimal psychological status whereby the belief that a 
beneficial treatment has been received optimizes psychological variables, subsequently 
enabling the athlete to perform to their full potential. If this is in fact the case, then sport and 
exercise practitioners would perhaps be better to address such deficiencies, as opposed to 
attempting to bridge the gap by means of a false belief. This is particularly germane given the 
evidence that an individual susceptible to a false positive belief may be equally susceptible to 
a false negative belief (5, 7), and therefore the potential for belief effects to impact negatively 
on performance. 
While not all individuals will be placebo responsive in all situations, the understanding and 
prevention of placebo/nocebo responses should be the concern of sports and exercise 
practitioners. But how does the practitioner know if their athlete/exerciser is placebo 
responsive? Is placebo responsiveness a function of personality? Is it more of a contextual 
situational phenomenon, or a genetic predisposition?   
Attempts to identify a relationship between placebo effects and personality have indicated 
that certain psychological variables such as anxiety (26), extraversion (20), openness (35), 
and agreeableness (27) could be related to placebo responding. While these findings are 
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equivocal, data from social psychology (15) suggests that personality characteristics may 
predispose an individual to respond to a placebo, but that situational factors are likely to 
interact with these traits to determine the degree of response exhibited. For instance in 
medicine, saline solutions and sugar pills may fail to elicit a placebo response if the 
psychosocial context is absent, the response to placebo influenced by factors including the 
practitioners’ clothing, the instruments used, the appearance of the room or laboratory, the 
words communicated to the patient and the relationship between the practitioner and patient 
(1, 9, 19). All these characteristics may play a role in eliciting placebo effects and in 
influencing the individual’s response to treatment. 
Interestingly, recent research has suggested that placebo responsiveness may have a genetic 
basis. Patients with irritable bowel syndrome who possessed a specific gene were placebo 
responsive, whereas participants who had a variation of the gene were not (17). While this 
may offer an explanation as to why some individuals are placebo responsive, psychometric 
assessment of personality to identify potentially placebo responsive traits and assessment of 
beliefs and expectations may provide more accessible means by which to help alert sport and 
exercise practitioners to the potential for placebo responsiveness, and facilitate appropriate 
counsel.  
Capitalizing on the placebo component of treatments 
It is reasonable given the above to conclude that that the effectiveness of treatments is 
influenced by the relationship between the athlete and their practitioner, and that this, in turn 
is influenced by the trust held between them. However, while deception would not usually be 
expected to feature in a successful coach-athlete relationship, there is anecdotal evidence for 
the deceptive manipulation of belief in the field. Australian swim coach Harry Gallagher 
described how he used to doctor the watches and clocks at swimming pools to provide 
athletes with false negative feedback, ensuring that they swam ‘faster’ in competition than in 
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training (14). This application could backfire, however, as illustrated by Seligman et al. (30). 
The authors conducted an investigation to examine the impact of false negative feedback on 
the performance of swimmers. They found that swimmers who reported a pessimistic 
personality would swim slower in response to the receipt of false feedback, while optimists 
tried harder and swam faster. This suggests that in addition to problematic ethics of 
deception, the deliberate use of false feedback to produce a placebo effect might be 
counterproductive. An athlete falsely led to believe that they have ingested a powerful 
ergogenic aid might produce a better performance than usual, but that athlete – upon being 
either debriefed or inadvertently finding out – might have less trust in their coach in future. In 
any coaching relationship, although the drive for improvement and success is powerful, the 
need for trust and honesty is a critical factor.  
The examples presented above suggest that using a deceptive placebo treatment as a means to 
stimulate performance enhancement is unethical. However, using our knowledge about the 
impact of beliefs on performance to maximize the effects of a legitimate intervention, 
coaching plan, or nutritional strategy, is not. In short, a placebo treatment can be a legitimate 
treatment. If an athlete is provided with information about the benefits of a challenging 
training regime, they are more likely to believe that it will be effective, more likely to see it 
as worthwhile, and more likely to adhere to it. No deception is involved; the practitioner is 
simply using their understanding of the important role of belief to bring out the best in their 
athlete.  
Investigating the placebo component of treatments 
The ideas presented above of course warrant further research. While careful consideration of 
ethical guidelines for the conduct of both practice and research is of paramount importance, 
the use of deceptive methods in research has the potential to generate knowledge about the 
impact of beliefs on performance that cannot be obtained otherwise. It is also worth 
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highlighting that what is and what is not acceptable in research is a function of what ethics 
committees and journal editors deem appropriate methods for addressing often increasingly 
complex questions. Historical trends in research ethics suggest that as the result of changes in 
law, culture, or knowledge, practices considered legitimate at one point in time may not be so 
at a later date (and arguably vice-versa). For example, in the early days of drugs research, the 
identification and elimination of placebo responsive participants from clinical drug trials 
might have been deemed unethical. Such practice constituted what amounts to a self-selecting 
sample, deprived some participants of potentially effective treatments, and inflated observed 
drug effects. However, the practice has become increasingly widespread as drug companies 
strive to derive ever less ambiguous findings from increasingly expensive and time-
consuming drug trials (21). The ethics of research will to a certain extent always be guided by 
the shifting balance between the need to protect participants on the one hand, and the need to 
provide society with reliable information about the effects of interventions on the other.   
Conclusions  
Sport and exercise medicine is increasingly evidence-based. With growing interest in the 
links between mind and body, the placebo effect and related phenomena such as 
psychoneuroimmunology (2), have become the focus of medical research, academic enquiry 
and media speculation. Greater knowledge of the placebo effect will not only enhance our 
understanding of the interaction between mind and body, but will likely enhance our 
understanding of the findings of research, findings that form the basis of the evidence base of 
sports medicine. This will allow researchers in a wide range of scientific and academic 
disciplines to make more reliable estimates of the effects of the interventions under 
investigation. 
Despite the attempts of many scientists to argue otherwise (18), the placebo effect is likely 
both a legitimate phenomenon and an evolved adaptive mechanism. Like many other 
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adaptive mechanisms, evidence suggests that we, or those from whom we seek help or 
advice, may be able to ‘tap in’ to these mechanisms when a certain set of environmental 
conditions are met. Such a set of environmental conditions is, for example, when there is a 
desired state (e.g. a certain level of health or performance), a difference between our current 
state and that desired state (an illness or low level or performance), a mechanism we believe 
may enhance our chances of reaching the desired state (e.g. a course of antibiotics or a sports 
intervention), and the belief that the intervention has been received. This does not discount 
the legitimacy of either antibiotics or sport psychology interventions, it merely highlights that 
a treatment in which an individual holds a strong and positive belief is more likely to elicit a 
positive placebo response that might augment the treatment response.  
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FIGURE LEGENDS 
Figure 1: The balanced placebo design (adapted from Rohsenow & Marlatt (28)) 
 
